CATALYST PHARMACEUTICALS, INC.
CPRXCatalyst Pharmaceuticals, Inc. is a biopharmaceutical company based in Coral Gables, Florida, United States. The company develops medicines for rare diseases, including the phosphate salt of amifampridine for the treatment of Lambert–Eaton myasthenic syndrome (LEMS). The drug is referred to under the trade name Firdapse, which was approved by the FDA for approved use in children 6 years and older with LEMS in addition to the prior approval for use in adults with LEMS on November 28, 2018. Firdapse commercially launched in January 2019.
Drugs in Pipeline
4
Phase 3 Programs
2
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 0 past
No catalysts found.
How CPRX's past catalysts played out
vigabatrin
Cocaine Dependence
Amifampridine Phosphate
Lambert Eaton Myasthenic Syndrome
Coagulation Factor IX variant
Hemophilia B
Coagulation Factor VIIa variant
Hemophilia A With Inhibitor
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
vigabatrin | Phase 3 | Cocaine Dependence | - | - |
Amifampridine Phosphate | Phase 3 | Lambert Eaton Myasthenic Syndrome | - | - |
Coagulation Factor IX variant | Phase 2 | Hemophilia B | - | - |
Coagulation Factor VIIa variant | Phase 2 | Hemophilia A With Inhibitor | - | - |
Frequently asked questions
What is in CATALYST PHARMACEUTICALS, INC.'s drug pipeline?→
CatalystAlert tracks 4 drug candidates in CATALYST PHARMACEUTICALS, INC.'s (CPRX) pipeline across Phase 3, Phase 2. Its lead program is vigabatrin (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is CATALYST PHARMACEUTICALS, INC.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for CATALYST PHARMACEUTICALS, INC. (CPRX) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track CPRX biotech catalysts?→
Add CPRX to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow CATALYST PHARMACEUTICALS, INC.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.